Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortive Corporation stock logo
FTV
Fortive
$64.09
+1.9%
$61.01
$46.34
$64.56
$19.03B1.062.37 million shs4.22 million shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.39
+2.2%
$1.45
$1.09
$2.73
$422.42M2.295.63 million shs7.91 million shs
10x Genomics stock logo
TXG
10x Genomics
$47.05
+2.5%
$35.67
$11.16
$49.50
$5.83B2.052.82 million shs2.57 million shs
Veralto Corporation stock logo
VLTO
Veralto
$98.34
+4.3%
$88.05
$80.03
$110.11
$23.16B0.631.70 million shs3.14 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortive Corporation stock logo
FTV
Fortive
+0.73%+2.91%+1.86%+1.63%+22.01%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
0.00%0.00%-17.58%-13.92%-11.69%
10x Genomics stock logo
TXG
10x Genomics
-0.76%+6.25%+24.95%+114.88%+225.44%
Veralto Corporation stock logo
VLTO
Veralto
+2.30%+1.00%+4.83%+10.00%-8.94%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortive Corporation stock logo
FTV
Fortive
$64.09
+1.9%
$61.01
$46.34
$64.56
$19.03B1.062.37 million shs4.22 million shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.39
+2.2%
$1.45
$1.09
$2.73
$422.42M2.295.63 million shs7.91 million shs
10x Genomics stock logo
TXG
10x Genomics
$47.05
+2.5%
$35.67
$11.16
$49.50
$5.83B2.052.82 million shs2.57 million shs
Veralto Corporation stock logo
VLTO
Veralto
$98.34
+4.3%
$88.05
$80.03
$110.11
$23.16B0.631.70 million shs3.14 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortive Corporation stock logo
FTV
Fortive
+0.73%+2.91%+1.86%+1.63%+22.01%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
0.00%0.00%-17.58%-13.92%-11.69%
10x Genomics stock logo
TXG
10x Genomics
-0.76%+6.25%+24.95%+114.88%+225.44%
Veralto Corporation stock logo
VLTO
Veralto
+2.30%+1.00%+4.83%+10.00%-8.94%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fortive Corporation stock logo
FTV
Fortive
2.00
Hold$63.00-1.70% Downside
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
1.80
Reduce$1.8331.89% Upside
10x Genomics stock logo
TXG
10x Genomics
2.20
Hold$32.08-31.81% Downside
Veralto Corporation stock logo
VLTO
Veralto
2.45
Hold$106.338.13% Upside

Current Analyst Ratings Breakdown

Latest TXG, PACB, VLTO, and FTV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/20/2026
Veralto Corporation stock logo
VLTO
Veralto
Boost Price TargetBuy$110.00 ➝ $111.00
7/17/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Reiterated RatingSell (E+)
7/17/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetMarket Perform$23.00 ➝ $40.00
7/15/2026
10x Genomics stock logo
TXG
10x Genomics
Reiterated RatingHold
7/14/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetBuy$32.00 ➝ $50.00
7/9/2026
Veralto Corporation stock logo
VLTO
Veralto
Reiterated RatingOutperform$109.00
7/9/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetEqual Weight$22.00 ➝ $37.00
7/8/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$24.00 ➝ $45.00
7/2/2026
Fortive Corporation stock logo
FTV
Fortive
Boost Price TargetHold$61.00 ➝ $67.00
7/1/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$20.00 ➝ $42.00
6/24/2026
10x Genomics stock logo
TXG
10x Genomics
Reiterated RatingSell (D-)
(Data available from 7/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fortive Corporation stock logo
FTV
Fortive
$4.16B4.66$4.31 per share14.87$20.34 per share3.15
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$160.01M2.70$0.81 per share1.72$0.02 per share69.50
10x Genomics stock logo
TXG
10x Genomics
$642.82M9.29N/AN/A$6.24 per share7.54
Veralto Corporation stock logo
VLTO
Veralto
$5.50B4.39$4.43 per share22.19$12.51 per share7.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fortive Corporation stock logo
FTV
Fortive
$579.20M$1.6738.3820.03N/A12.84%12.66%6.98%7/29/2026 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$546.38M-$0.43N/AN/AN/A-80.35%-571.06%-18.82%8/3/2026 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.17N/AN/AN/A-3.55%-2.86%-2.23%8/6/2026 (Estimated)
Veralto Corporation stock logo
VLTO
Veralto
$940M$3.8723.4021.152.6617.33%34.63%13.44%7/28/2026 (Estimated)

Latest TXG, PACB, VLTO, and FTV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.23N/AN/AN/A$146.67 millionN/A
8/3/2026Q2 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.1280N/AN/AN/A$42.90 millionN/A
7/29/2026Q2 2026
Fortive Corporation stock logo
FTV
Fortive
$0.71N/AN/AN/A$1.07 billionN/A
7/28/2026Q2 2026
Veralto Corporation stock logo
VLTO
Veralto
$1.01$1.11+$0.10$0.98$1.45 billion$1.47 billion
5/7/2026Q1 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.17-$0.12+$0.05-$0.03$39.94 million$37.18 million
5/7/2026Q1 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.29-$0.10+$0.19-$0.10$146.41 million$150.84 million
4/30/2026Q1 2026
Fortive Corporation stock logo
FTV
Fortive
$0.64$0.70+$0.06$0.44$1.04 billion$2.14 billion
4/28/2026Q1 2026
Veralto Corporation stock logo
VLTO
Veralto
$1.02$1.07+$0.05$1.02$1.40 billion$1.42 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fortive Corporation stock logo
FTV
Fortive
$0.240.37%+5.57%14.37%2 Years
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A
Veralto Corporation stock logo
VLTO
Veralto
$0.520.53%N/A13.44%1 Years

Latest TXG, PACB, VLTO, and FTV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/13/2026
Veralto Corporation stock logo
VLTO
Veralto
quarterly$0.130.59%6/30/20266/30/20267/31/2026
6/9/2026
Fortive Corporation stock logo
FTV
Fortive
quarterly$0.060.39%6/22/20266/22/20267/6/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fortive Corporation stock logo
FTV
Fortive
0.43
0.71
0.57
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
5.65
4.87
10x Genomics stock logo
TXG
10x Genomics
N/A
5.90
5.42
Veralto Corporation stock logo
VLTO
Veralto
0.65
1.48
1.32

Institutional Ownership

CompanyInstitutional Ownership
Fortive Corporation stock logo
FTV
Fortive
94.94%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
10x Genomics stock logo
TXG
10x Genomics
84.68%
Veralto Corporation stock logo
VLTO
Veralto
91.28%

Insider Ownership

CompanyInsider Ownership
Fortive Corporation stock logo
FTV
Fortive
0.65%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
3.70%
10x Genomics stock logo
TXG
10x Genomics
8.84%
Veralto Corporation stock logo
VLTO
Veralto
0.43%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fortive Corporation stock logo
FTV
Fortive
10,000302.40 million300.43 millionOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730310.60 million299.11 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240126.96 million115.73 millionOptionable
Veralto Corporation stock logo
VLTO
Veralto
17,000245.60 million244.54 millionOptionable

Recent News About These Companies

Veralto Reports Second Quarter 2026 Results
Veralto (VLTO) Projected to Post Quarterly Earnings on Tuesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fortive stock logo

Fortive NYSE:FTV

$64.09 +1.17 (+1.86%)
Closing price 03:59 PM Eastern
Extended Trading
$65.15 +1.06 (+1.65%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.39 +0.03 (+2.21%)
Closing price 04:00 PM Eastern
Extended Trading
$1.40 +0.01 (+0.36%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$47.05 +1.13 (+2.46%)
Closing price 04:00 PM Eastern
Extended Trading
$47.53 +0.48 (+1.02%)
As of 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Veralto stock logo

Veralto NYSE:VLTO

$98.34 +4.06 (+4.30%)
Closing price 03:59 PM Eastern
Extended Trading
$100.74 +2.40 (+2.44%)
As of 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands. This segment provides water solutions, including chemical reagents, services, and digital solutions. The PQI segment offers inline printing solutions for products and packaging with marking and coding systems; marking and coding for packaged goods and related consumables; design software and imaging systems for the creation of new packaging designs; color management solutions for printed packages and consumer and industrial products; color standard services for the design industry; and a software solution that provides digital asset management, marketing resource management, and product information management. This segment sells its products and services through the Videojet, Linx, Esko, X-Rite, and Pantone brands to regulated industries, including municipal utilities, food and beverage, pharmaceutical, and industrials. The company was formerly known as DH EAS Holding Corp. and changed its name to Veralto Corporation in February 2023. Veralto Corporation was incorporated in 2022 and is headquartered in Waltham, Massachusetts.